BlackRock Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $49.5M | Sell |
671,795
-598,238
| -47% | -$44.1M | 0.06% | 313 |
|
|
2016
Q3 | $111M | Sell |
1,270,033
-10,990
| -0.9% | -$958K | 0.14% | 154 |
|
|
2016
Q2 | $110M | Sell |
1,281,023
-442,008
| -26% | -$38M | 0.14% | 152 |
|
|
2016
Q1 | $137M | Buy |
1,723,031
+204,299
| +13% | +$16.2M | 0.18% | 115 |
|
|
2015
Q4 | $191M | Buy |
1,518,732
+443,445
| +41% | +$55.8M | 0.24% | 93 |
|
|
2015
Q3 | $112M | Sell |
1,075,287
-1,025,932
| -49% | -$107M | 0.15% | 139 |
|
|
2015
Q2 | $259M | Buy |
2,101,219
+31,381
| +2% | +$3.87M | 0.32% | 66 |
|
|
2015
Q1 | $244M | Buy |
2,069,838
+325,754
| +19% | +$38.4M | 0.32% | 67 |
|
|
2014
Q4 | $207M | Buy |
1,744,084
+636,117
| +57% | +$75.6M | 0.27% | 78 |
|
|
2014
Q3 | $124M | Buy |
1,107,967
+569,494
| +106% | +$64M | 0.17% | 124 |
|
|
2014
Q2 | $51M | Buy |
538,473
+73,049
| +16% | +$6.92M | 0.07% | 282 |
|
|
2014
Q1 | $32.9M | Buy |
465,424
+16,424
| +4% | +$1.16M | 0.05% | 353 |
|
|
2013
Q4 | $33.4M | Sell |
449,000
-12,726
| -3% | -$946K | 0.05% | 335 |
|
|
2013
Q3 | $35M | Sell |
461,726
-102,255
| -18% | -$7.75M | 0.06% | 304 |
|
|
2013
Q2 | $45.2M | Buy |
+563,981
| New | +$45.2M | 0.08% | 223 |
|